Press releases
- Dexcom Announces Upcoming Conference Presentation
- Dexcom Showcases Accuracy, Reliability and Ease of Use of Its Dexcom G6 CGM System at the 66th Annual Meeting of the Japan Diabetes Society
- Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028
- Dexcom rtCGM is Likely to be Cost-Saving, Study Suggests
- Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes
- Dexcom Reports First Quarter 2023 Financial Results
- Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB
- Dexcom Commends Decision to Expand CGM Medicare Coverage to Include People With Diabetes Using All Types of Insulin
- Dexcom Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 at 4:30 p.m. Eastern Time
- Dexcom Publishes Annual Sustainability Report
More ▼
Key statistics
As of last trade Dexcom Inc (DC4:DUS) traded at 113.64, -7.37% below its 52-week high of 122.68, set on Oct 31, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 113.64 |
---|---|
High | 113.64 |
Low | 113.64 |
Bid | 114.46 |
Offer | 115.38 |
Previous close | 110.68 |
Average volume | 26.64 |
---|---|
Shares outstanding | 387.64m |
Free float | 384.65m |
P/E (TTM) | 177.62 |
Market cap | 47.51bn USD |
EPS (TTM) | 0.6901 USD |
Data delayed at least 15 minutes, as of Jun 05 2023 07:10 BST.
More ▼